Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Optimal management of chronic limb-threatening ischemia in patients lacking consensus on initial revascularization strategy

FY 2022-23

Summary
Chronic limb-threatening ischemia (CLTI) is the end-stage of peripheral vascular disease that is characterized by persistent pain, gangrene, and tissue loss. Over the past two decades, there has been an increasing adoption of endovascular-first approach to treat CLTI. Previous research demonstrated that non-selective revascularization favouring endovascular-first approach can be problematic with decreased amputation-free and overall survival in patients who require open bypass after failed endovascular revascularization. The Global Limb Anatomic Staging System (GLASS) and the Wound, Ischemia, and foot Infection (WIfI) classification system were developed to guide decision-making in treatment of CLTI by suggesting preferred initial revascularization strategy. However, there remains a grey zone of patients lacking consensus on the initial approach to revascularization. The goal of this study was to identify the optimal management for patients in the grey zone according to GLASS and WIfI stages. A retrospective observational study will be conducted including 900 patients with CLTI who underwent first-time endovascular or open revascularization between January 2007 and December 2017 at two McGill University-affiliated hospitals. The primary endpoints include 1- and 5-year major adverse limb event. The secondary endpoints include 1- and 5-year amputation, reintervention, and complete foot healing. Kaplan-Meier analysis will be used to estimate freedom from these events stratified by GLASS and WIfI stages. Cox regression analysis will be used to adjust for baseline differences among these groups. Consideration of GLASS as a prognostic tool to identify the optimal strategy for initial revascularization in patients in the grey zone may potentially improve patient outcomes.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486386
Name
Kim Ye Seul
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Optimal management of chronic limb-threatening ischemia in patients lacking consensus on initial revascularization strategy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Limb-Threatening Ischemia; Global Limb Anatomic Staging System; Limb Salvage; Peripheral Artery Disease; Revascularization
Abstract
Chronic limb-threatening ischemia (CLTI) is the end-stage of peripheral vascular disease that is characterized by persistent pain, gangrene, and tissue loss. Over the past two decades, there has been an increasing adoption of endovascular-first approach to treat CLTI. Previous research demonstrated that non-selective revascularization favouring endovascular-first approach can be problematic with decreased amputation-free and overall survival in patients who require open bypass after failed endovascular revascularization. The Global Limb Anatomic Staging System (GLASS) and the Wound, Ischemia, and foot Infection (WIfI) classification system were developed to guide decision-making in treatment of CLTI by suggesting preferred initial revascularization strategy. However, there remains a grey zone of patients lacking consensus on the initial approach to revascularization. The goal of this study was to identify the optimal management for patients in the grey zone according to GLASS and WIfI stages. A retrospective observational study will be conducted including 900 patients with CLTI who underwent first-time endovascular or open revascularization between January 2007 and December 2017 at two McGill University-affiliated hospitals. The primary endpoints include 1- and 5-year major adverse limb event. The secondary endpoints include 1- and 5-year amputation, reintervention, and complete foot healing. Kaplan-Meier analysis will be used to estimate freedom from these events stratified by GLASS and WIfI stages. Cox regression analysis will be used to adjust for baseline differences among these groups. Consideration of GLASS as a prognostic tool to identify the optimal strategy for initial revascularization in patients in the grey zone may potentially improve patient outcomes.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kim, Ye Seul
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~